186 related articles for article (PubMed ID: 11099651)
1. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells.
Burczynski ME; McMillian M; Ciervo J; Li L; Parker JB; Dunn RT; Hicken S; Farr S; Johnson MD
Toxicol Sci; 2000 Dec; 58(2):399-415. PubMed ID: 11099651
[TBL] [Abstract][Full Text] [Related]
2. Identification of genes associated with sensitivity to 5-fluorouracil and cisplatin in hepatoma cells.
Hoshida Y; Moriyama M; Otsuka M; Kato N; Goto T; Taniguchi H; Shiratori Y; Seki N; Omata M
J Gastroenterol; 2002 Nov; 37 Suppl 14():92-5. PubMed ID: 12572874
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells.
Qin LF; Ng IO
Cancer Lett; 2002 Jan; 175(1):27-38. PubMed ID: 11734333
[TBL] [Abstract][Full Text] [Related]
4. [Study of cooperation of tumor suppressor p33(ING1b) with p53 gene in hepatocellular carcinoma].
Zhu Z; Lin J; Qu JH; Li FM; Ni CR; Zhu MH
Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1795-800. PubMed ID: 14642087
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.
Cai S; Bai Y; Wang H; Zhao Z; Ding X; Zhang H; Zhang X; Liu Y; Jia Y; Li Y; Chen S; Zhou H; Liu H; Yang C; Sun T
J Exp Clin Cancer Res; 2020 Jul; 39(1):135. PubMed ID: 32669125
[TBL] [Abstract][Full Text] [Related]
6. Relevance network between chemosensitivity and transcriptome in human hepatoma cells.
Moriyama M; Hoshida Y; Otsuka M; Nishimura S; Kato N; Goto T; Taniguchi H; Shiratori Y; Seki N; Omata M
Mol Cancer Ther; 2003 Feb; 2(2):199-205. PubMed ID: 12589037
[TBL] [Abstract][Full Text] [Related]
7. Exogenous expression of p21(WAF1/CIP1) exerts cell growth inhibition and enhances sensitivity to cisplatin in hepatoma cells.
Qin LF; Ng IO
Cancer Lett; 2001 Oct; 172(1):7-15. PubMed ID: 11595124
[TBL] [Abstract][Full Text] [Related]
8. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of cisplatin-induced transcriptomics responses in primary mouse hepatocytes, HepG2 cells and mouse embryonic stem cells shows conservation of regulating transcription factor networks.
Rieswijk L; Lizarraga D; Brauers KJ; Kleinjans JC; van Delft JH
Mutagenesis; 2014 Jan; 29(1):17-26. PubMed ID: 24280081
[TBL] [Abstract][Full Text] [Related]
10. The use of genomics technology to investigate gene expression changes in cultured human liver cells.
Harries HM; Fletcher ST; Duggan CM; Baker VA
Toxicol In Vitro; 2001; 15(4-5):399-405. PubMed ID: 11566570
[TBL] [Abstract][Full Text] [Related]
11. The involvement of XPC protein in the cisplatin DNA damaging treatment-mediated cellular response.
Wang G; Dombkowski A; Chuang L; Xu XX
Cell Res; 2004 Aug; 14(4):303-14. PubMed ID: 15353127
[TBL] [Abstract][Full Text] [Related]
12. Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells.
Abiru S; Nakao K; Ichikawa T; Migita K; Shigeno M; Sakamoto M; Ishikawa H; Hamasaki K; Nakata K; Eguchi K
Hepatology; 2002 May; 35(5):1117-24. PubMed ID: 11981761
[TBL] [Abstract][Full Text] [Related]
13. Expression profiling after activation of amino acid deprivation response in HepG2 human hepatoma cells.
Shan J; Lopez MC; Baker HV; Kilberg MS
Physiol Genomics; 2010 May; 41(3):315-27. PubMed ID: 20215415
[TBL] [Abstract][Full Text] [Related]
14. Application of cDNA microarray to the study of arsenic-induced liver diseases in the population of Guizhou, China.
Lu T; Liu J; LeCluyse EL; Zhou YS; Cheng ML; Waalkes MP
Toxicol Sci; 2001 Jan; 59(1):185-92. PubMed ID: 11134558
[TBL] [Abstract][Full Text] [Related]
15. A High-throughput Quantitative Expression Analysis of Cancer-related Genes in Human HepG2 Cells in Response to Limonene, a Potential Anticancer Agent.
Hafidh RR; Hussein SZ; MalAllah MQ; Abdulamir AS; Abu Bakar F
Curr Cancer Drug Targets; 2018; 18(8):807-815. PubMed ID: 29141549
[TBL] [Abstract][Full Text] [Related]
16. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.
Chiba T; Yokosuka O; Fukai K; Kojima H; Tada M; Arai M; Imazeki F; Saisho H
Oncology; 2004; 66(6):481-91. PubMed ID: 15452378
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation during p21WAF1/CIP1-induced apoptosis in human ovarian cancer cells.
Wu Q; Kirschmeier P; Hockenberry T; Yang TY; Brassard DL; Wang L; McClanahan T; Black S; Rizzi G; Musco ML; Mirza A; Liu S
J Biol Chem; 2002 Sep; 277(39):36329-37. PubMed ID: 12138103
[TBL] [Abstract][Full Text] [Related]
18. Relationship Between San-Huang-Xie-Xin-Tang and its herbal components on the gene expression profiles in HepG2 cells.
Cheng WY; Wu SL; Hsiang CY; Li CC; Lai TY; Lo HY; Shen WS; Lee CH; Chen JC; Wu HC; Ho TY
Am J Chin Med; 2008; 36(4):783-97. PubMed ID: 18711774
[TBL] [Abstract][Full Text] [Related]
19. Genomic interrogation of mechanism(s) underlying cellular responses to toxicants.
Amin RP; Hamadeh HK; Bushel PR; Bennett L; Afshari CA; Paules RS
Toxicology; 2002 Dec; 181-182():555-63. PubMed ID: 12505366
[TBL] [Abstract][Full Text] [Related]
20. Identification of Genes Selectively Regulated in Human Hepatoma Cells by Treatment With Dyslipidemic Sera and PUFAs.
De Rosa MC; Caputo M; Zirpoli H; Rescigno T; Tarallo R; Giurato G; Weisz A; Torino G; Tecce MF
J Cell Physiol; 2015 Sep; 230(9):2059-66. PubMed ID: 25639214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
